510(k) Report

510(k) · Cleared

Cleared

Concentriq Dx

K230839510(k) TraditionalCleared Feb 8, 2024318-day reviewClass II21 CFR 864.3700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Proscia, Inc. · PSY Whole Slide Imaging System

Cleared on Feb 8, 2024 as substantially equivalent to K213883 (Hamamatsu Photonics K.K., 2022) after a 318-day review. Its family tree reaches back 2 generations to 2017. 1 later device descends from it.

Decided
Feb 8, 2024
Review
318 days
Class
Class II
Product code
PSY
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN160056 (2017). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2026: 1 descendant clearedDEN160056 · Philips IntelliSite Pathology Solution · Philips Medical Systems Nederland B.V. · 2017K213883 · NanoZoomer S360MD Slide scanner system · Hamamatsu Photonics K.K. · 2022 · recalled201620182020202220242026
  1. Root · 2 generations backDEN160056 Philips IntelliSite Pathology SolutionPhilips Medical Systems Nederland B.V. · 2017
  2. 1 generation backK213883 NanoZoomer S360MD Slide scanner systemHamamatsu Photonics K.K. · 2022 · Recalled
  3. This deviceK230839 Concentriq DxProscia, Inc. · 2024
  4. Descendant · cites it directly · 0 of its ownK261380 Concentriq AP-DxProscia, Inc. · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K261380Concentriq AP-DxProscia, Inc. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN160056Philips IntelliSite Pathology SolutionPhilips Medical Systems Nederland B.V.2017—
−1K213883NanoZoomer S360MD Slide scanner systemHamamatsu Photonics K.K.20221
0 (this device)K230839Concentriq DxProscia, Inc.2024—
+1K261380Concentriq AP-DxProscia, Inc.2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K230839, 2017–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PSY device

  1. #1 K232202 Aperio GT 450 DXscore 34.5 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K213883NanoZoomer S360MD Slide scanner system
Summary page 5
…logy Image Viewing and Management Software PREDICATE DEVICE Proprietary Name: NanoZoomer S360MD Slide scanner system Submission Number: K213883 INDICATIONS FOR USE For In Vitro Diagnostic Use Concentriq® Dx is a software only device intended for viewing and management of…
Hamamatsu Photonics K.K.20221

Also cleared against K213883: 5 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K261380Concentriq AP-DxProscia, Inc.20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 5.5 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K261380 (Proscia, Inc., 2026) has gone furthest, with 0 descendants of its own.
  • 5 other devices also cite its predicate K213883.

How does its category compare?

All PSY devices

PSY Whole Slide Imaging System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · PSY

2in 2025

2017: 22019: 22021: 22022: 12023: 12024: 92025: 22026 (partial year): 4
2007high 9 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PSY

265in 2024

2024: 265 days median2026 (partial year): 253 days median
2007high 265 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PSY

1so far in 2026, the most since 2007

2026 (partial year): 1
2007high 1 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PSY

1in 2023

2019: 12020: 12023: 1
2007high 1 (2019) · low 0 (2007)2025

MAUDE reports naming product code PSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20172—00
20180—00
20192—01
20200—01
20212—00
20221—00
20231—01
2024926500
20252—00
202642531—

What is it indicated for?

For In Vitro Diagnostic Use Concentriq® Dx is a software only device intended for viewing and management of digital images of scanned surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue. It is an aid to the pathologist to review, interpret and manage these digital slide images for the purpose of primary diagnosis. Concentriq® Dx is not intended for use with frozen sections, cytology, or non-FFPE hematopathology…

Read the full statement (119 words)

For In Vitro Diagnostic Use

Concentriq® Dx is a software only device intended for viewing and management of digital images of scanned surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue. It is an aid to the pathologist to review, interpret and manage these digital slide images for the purpose of primary diagnosis. Concentriq® Dx is not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens.

It is the responsibility of a qualified pathologist to employ appropriate procedures and safeguards to assure the quality of the images obtained and the validity of the interpretation of images using Concentriq Dx. Concentriq Dx is intended for use with the Hamamatsu NanoZoomer S360MD Slide scanner and JVC JD-C240BN01A monitor.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K230839: Concentriq Dx.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K230839

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026